CoChat

Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials

Thomopoulos, Costas, Parati, Gianfranco, Zanchetti, Alberto · 2017 · Journal of Hypertension

The DOI matches its Crossref record; 152 of the 155 references it cites were found in a registry or an index.

Abstract

Background Type 2 diabetes mellitus is associated with an increased risk of hypertension, and cardiovascular and renal disease, and it has been recommended that management of hypertension should be more aggressive in presence than in absence of diabetes mellitus, but the matter is controversial at present. Objectives Meta-analysing all available randomized controlled trials (RCTs) to compare the effects on cardiovascular and renal outcomes of blood pressure BP lowering to different systolic BP (SBP) and diastolic BP (DBP) levels or by different drug classes in patients with and without diabetes mellitus. Methods The database consisted of 72 BP-lowering RCTs (260 210 patients) and 50 head-to-head drug comparison RCTs (247 006). Among these two sets, RCTs or RCT subgroups separately reporting data from patients with and without diabetes mellitus were identified, and stratified by in-treatment achieved SBP and DBP, by drug class compared with placebo, and drug class compared with all other classes. Risk ratios and 95% confidence intervals, and absolute risk reductions of six fatal and non-fatal cardiovascular outcomes, all-cause death, and end-stage renal disease (ESRD) were calculated (random-effects model) separately for diabetes mellitus and no diabetes mellitus, and compared by interaction analysis. Results We identified 41 RCTs providing data on 61 772 patients with diabetes mellitus and 40 RCTs providing data on 191 353 patients without diabetes mellitus. For achieved SBP…

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0000000000001276

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 152 references

Research works printed but not linked: 8

  1. 1998, 2 diabetes: UKPDS 38., BMJ, 317, 703
  2. 2010, 2 diabetes mellitus., N Engl J Med, 362, 1575
  3. 2007, 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial., Lancet, 37, 829
  4. 2008, Hypertens R, es, 31, 2115
  5. 2010, N Engl J M, ed, 362, 1477
  6. 2004, N Engl J M, ed, 351, 2058
  7. 2015, N Engl J M, ed, 373, 2103
  8. Baghdasarian, 2006, Effect of amlodipine and enalapril on cardiovascular events in patients with insulin resistance and diabetes in the CAMELOT trial, J Am Coll Cardiol, 47, 310A

Cited by

See all 206

Metadata

Authors
Thomopoulos, C., Parati, G., & Zanchetti, A.
Affiliations
University of Milan (IT)
Corresponding author
Zanchetti, Alberto
Venue
Journal of Hypertension
Published
2017-05
Volume
35
Issue
5
Pages
922-944
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2587222377
Cited by
206
References
155
Citations by year
2026: 7 · 2025: 11 · 2024: 15 · 2023: 18 · 2022: 23 · 2021: 21 · 2020: 38 · 2019: 34 · 2018: 30 · 2017: 9
FWCI
4.28
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
hypertension, type 2 diabetes, blood pressure reduction, antihypertensive drugs, cardiovascular outcomes, end-stage renal disease, ACE inhibitors, renin-angiotensin system inhibitors, systolic blood pressure target, drug class comparison, all-cause mortality, cardiovascular disease prevention, interaction analysis
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hypertension, Kidney Failure, Chronic, Risk Factors, Incidence, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. https://app.cochat.ai/papers/10.1097/hjh.0000000000001276
The paper
Thomopoulos, C., Parati, G., & Zanchetti, A. (2017). Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000001276

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.